SSFA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.656400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.669800E-01
Normal-vs-Stage2
2.091400E-01
Normal-vs-Stage3
2.849600E-01
Normal-vs-Stage4
2.537400E-01
Stage1-vs-Stage2
6.277600E-01
Stage1-vs-Stage3
8.466000E-01
Stage1-vs-Stage4
3.040400E-01
Stage2-vs-Stage3
8.585600E-01
Stage2-vs-Stage4
4.846200E-01
Stage3-vs-Stage4
4.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.797600E-01
Normal-vs-AfricanAmerican
1.546400E-01
Normal-vs-Asian
2.966200E-01
Caucasian-vs-AfricanAmerican
3.042200E-01
Caucasian-vs-Asian
4.434200E-01
AfricanAmerican-vs-Asian
7.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.724600E-01
Normal-vs-Female
2.592800E-01
Male-vs-Female
2.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.760600E-01
Normal-vs-Age(41-60Yrs)
2.287600E-01
Normal-vs-Age(61-80Yrs)
2.771200E-01
Normal-vs-Age(81-100Yrs)
4.758200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.327400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.014200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.951200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.738400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.928170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.324200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.389000E-01
Normal-vs-Daily Drinker
6.957800E-01
Normal-vs-Weekly Drinker
3.708200E-01
Normal-vs-Occasional Drinker
1.788600E-01
Normal-vs-Social Drinker
3.429000E-01
Non Drinker-vs-Daily Drinker
6.280300E-02
Non Drinker-vs-Weekly Drinker
6.476000E-01
Non Drinker-vs-Occasional Drinker
8.160200E-01
Non Drinker-vs-Social Drinker
1.481450E-01
Daily Drinker-vs-Weekly Drinker
1.527590E-01
Daily Drinker-vs-Occasional Drinker
4.934200E-02
Daily Drinker-vs-Social Drinker
5.529800E-01
Weekly Drinker-vs-Occasional Drinker
7.544600E-01
Weekly Drinker-vs-Social Drinker
2.442600E-01
Occasional Drinker-vs-Social Drinker
1.390000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.958000E-02
Normal-vs-Grade 2
2.714300E-02
Normal-vs-Grade 3
1.015860E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.164900E-03
Grade 1-vs-Grade 3
7.354100E-04
Grade 1-vs-Grade 4
9.958000E-02
Grade 2-vs-Grade 3
4.539800E-01
Grade 2-vs-Grade 4
2.714300E-02
Grade 3-vs-Grade 4
1.015860E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.177800E-01
Normal-vs-NonDiabetic
3.044200E-01
Diabetic-vs-NonDiabetic
2.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.067200E-01
Normal-vs-NoPancreatitis
3.056000E-01
Pancreatitis-vs-NoPancreatitis
1.128250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.201800E-01
Normal-vs-N1
1.981160E-01
N0-vs-N1
2.380800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.068640E-01
Normal-vs-TP53-NonMutant
3.591000E-01
TP53-Mutant-vs-TP53-NonMutant
5.739600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
